MaxCyte Inc

NASDAQ:MXCTUnited States

MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support cell-based research and development. It has developed and commercialized its proprietary Flow Electroporation technology, which is used by biopharmaceutical companies in the complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address this rapidly expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes four instruments, which are known as the ATx, STx, GTx and VLx, as well as a portfolio of proprietary related disposables and consumables.

Contact Information

Headquarters

9713 KEY WEST AVENUE,, SUITE 400ROCKVILLE, MD, United States 20850

Phone

301-517-5556

Fax

301-944-1703

Executives

Non-Executive Independent Chairman of the Board

Richard Douglas

President, Chief Executive Officer, Director

Maher Masoud

Chief Financial Officer

Douglas Swirsky

Executive Vice President - Global Sales

Thomas Ross

Senior Vice President, General Counsel, Corporate Secretary

David Sandoval